AMICUS THERAPEUTICS, INC. — Director's Dealing 2025

Nov 26, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2025-11-24

Reporting Person: Rosenberg Ellen (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-11-24	Common Stock	M	25000	$6.1	Acquired	532710	Direct
2025-11-24	Common Stock	M	11000	$5.13	Acquired	543710	Direct
2025-11-24	Common Stock	S	36000	$10.0630	Disposed	507710	Direct
2025-11-25	Common Stock	M	36000	$5.13	Acquired	543710	Direct
2025-11-25	Common Stock	S	36000	$10	Disposed	507710	Direct
2025-11-26	Common Stock	M	23621	$5.13	Acquired	531331	Direct
2025-11-26	Common Stock	S	23621	$10	Disposed	507710	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-11-24	Stock Options (right to buy)	$6.10	M	25000	Disposed	2026-06-15	Common Stock (25000)	Direct
2025-11-24	Stock Options (right to buy)	$5.13	M	11000	Disposed	2027-01-03	Common Stock (11000)	Direct
2025-11-25	Stock Options (right to buy)	$5.13	M	36000	Disposed	2027-01-03	Common Stock (36000)	Direct
2025-11-26	Stock Options (right to buy)	$5.13	M	23621	Disposed	2027-01-03	Common Stock (23621)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	15000	Indirect

Footnotes

F1: This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.00 to $10.31 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: All of the options were fully vested and exercisable as of the transaction date.